Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02838875
Other study ID # 0253-16-TLV
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received July 18, 2016
Last updated July 18, 2016
Start date August 2016
Est. completion date August 2019

Study information

Verified date July 2016
Source Tel-Aviv Sourasky Medical Center
Contact Yariv Yogev, professor
Phone 052-7360616
Email yarivy@tlvmc.gov.il
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

Background Neonatal hypoglycemia is one of the most common metabolic disorders in neonatology. Maintaining stable levels of glucose in the transition from fetal life to life after birth is very important. Yet, except for the recognizing of at-risk populations, there are not many individual measures which can help and predict which newborns (from at-risk populations) will develop hypoglycemia and which will not.

OBJECTIVE our objective is to try to characterize by the mother's glucose levels at birth and by umbilical cord glucose levels who would be at increased risk of hypoglycemia in the hours after birth in the population that is at increased risk of this complication in advance.


Description:

Background Neonatal hypoglycemia is one of the most common metabolic disorders in neonatology. Maintaining stable levels of glucose in the transition from fetal life to life after birth is very important. Yet, except for the recognizing of at-risk populations, there are not many individual measures which can help and predict which newborns (from at-risk populations) will develop hypoglycemia and which will not.

OBJECTIVE our objective is to try to characterize by the mother's glucose levels at birth and by umbilical cord glucose levels who would be at increased risk of hypoglycemia in the hours after birth in the population that is at increased risk of this complication in advance.

PATIENTS & METHODS All women who arrived to the delivery room at Lis hospital and which the newborn is about to undergo glucose levels follow-up after birth regardless the study, because his affiliation to the at-risk population including: delivery below 37th week, maternal diabetes during pregnancy and newborns in weight under percentile 10 or above percentile 90 by Dolberg graphs.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1000
Est. completion date August 2019
Est. primary completion date August 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

1. Single pregnancy

2. Vaginal or cesarean birth.

3. Births where there is an indication of neonatal hypoglycemia follow-up - one or more of the following:

- Delivery week below 37 full weeks.

- Maternal diabetes during pregnancy (gestational diabetes or pre-gestational).

- Newborn under percentile 10 by Dolberg graph.

- Newborn above percentile 90 by Dolberg graph.

Exclusion Criteria:

1. Multiple Pregnancy

2. pregnancies in which there is no indication for routine monitoring of glucose levels after birth

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
Blood samples
After birth - taking blood sample from the umbilical cord (arterial and venous) + blood sample from the patient.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Tel-Aviv Sourasky Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Cord blood glucose levels as a predictor to newborns Hypoglycemia Taking blood samples as a predictor to number of Hypoglycemic children. 2 weeks No
See also
  Status Clinical Trial Phase
Completed NCT02583776 - Continuous Glucose Monitoring and Preterm Infants Phase 4
Not yet recruiting NCT05977972 - Pattern of Metabolic Causes of Neonatal Hypoglycemia
Recruiting NCT04458649 - Continuous Glucose Monitoring in Infants
Recruiting NCT05127070 - Evaluating the NeoTree in Malawi and Zimbabwe
Completed NCT03032523 - Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM) N/A
Completed NCT03726697 - Effect of Tahneek on Hypoglycemia in Newborn Infants N/A
Terminated NCT04085978 - Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
Recruiting NCT05647798 - Intrapartum Glycemic Control in GDMA2 N/A
Not yet recruiting NCT04811612 - Comparing Heel Stick Glucoses in Neonates N/A
Not yet recruiting NCT02648555 - A Lifestyle Intervention to Improve in Vitro Fertilization Results N/A
Recruiting NCT06373432 - Frequency of Glucose Monitoring in Labor N/A
Completed NCT04030312 - Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant N/A
Completed NCT03076775 - Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study N/A
Completed NCT05022433 - Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
Recruiting NCT00332449 - Early Breast Feeding and Glucose Levels in High Risk Newborns N/A
Not yet recruiting NCT04869709 - Late Preterm Corticosteroids and Neonatal Hypoglycemia Phase 4
Completed NCT02523222 - Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia N/A
Recruiting NCT04875624 - Neurodevelopment of Hypoglycemic Neonates
Completed NCT02605369 - SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan N/A
Withdrawn NCT03738293 - Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids